Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOTAC PHARMACEUTICALS LTD. vs SAMRAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SOTAC PHARMACEUTICALS LTD. SAMRAT PHARMA SOTAC PHARMACEUTICALS LTD./
SAMRAT PHARMA
 
P/E (TTM) x - 38.1 - View Chart
P/BV x 2.9 2.1 137.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 SOTAC PHARMACEUTICALS LTD.   SAMRAT PHARMA
EQUITY SHARE DATA
    SOTAC PHARMACEUTICALS LTD.
Mar-24
SAMRAT PHARMA
Mar-24
SOTAC PHARMACEUTICALS LTD./
SAMRAT PHARMA
5-Yr Chart
Click to enlarge
High Rs155604 25.6%   
Low Rs97320 30.3%   
Sales per share (Unadj.) Rs94.0911.3 10.3%  
Earnings per share (Unadj.) Rs3.27.0 46.3%  
Cash flow per share (Unadj.) Rs6.09.1 66.5%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Avg Dividend yield %00.2 0.0%  
Book value per share (Unadj.) Rs41.0210.3 19.5%  
Shares outstanding (eoy) m11.053.09 357.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.5 264.4%   
Avg P/E ratio x38.966.0 58.9%  
P/CF ratio (eoy) x20.850.8 41.0%  
Price / Book Value ratio x3.12.2 140.0%  
Dividend payout %014.3 0.0%   
Avg Mkt Cap Rs m1,3921,428 97.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2011 184.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,0382,816 36.9%  
Other income Rs m514 35.1%   
Total revenues Rs m1,0432,830 36.9%   
Gross profit Rs m8325 336.7%  
Depreciation Rs m316 479.3%   
Interest Rs m177 253.0%   
Profit before tax Rs m4025 157.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m44 107.5%   
Profit after tax Rs m3622 165.5%  
Gross profit margin %8.00.9 913.2%  
Effective tax rate %9.714.2 68.4%   
Net profit margin %3.40.8 448.8%  
BALANCE SHEET DATA
Current assets Rs m6061,026 59.1%   
Current liabilities Rs m437564 77.5%   
Net working cap to sales %16.316.4 99.4%  
Current ratio x1.41.8 76.3%  
Inventory Days Days911 84.1%  
Debtors Days Days924898 102.9%  
Net fixed assets Rs m433192 225.7%   
Share capital Rs m11131 357.6%   
"Free" reserves Rs m342619 55.3%   
Net worth Rs m453650 69.6%   
Long term debt Rs m1210-   
Total assets Rs m1,0391,217 85.3%  
Interest coverage x3.34.7 70.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x1.02.3 43.2%   
Return on assets %5.12.3 218.6%  
Return on equity %7.93.3 237.7%  
Return on capital %9.94.9 201.3%  
Exports to sales %02.0 0.0%   
Imports to sales %083.5 0.0%   
Exports (fob) Rs mNA58 0.0%   
Imports (cif) Rs mNA2,350 0.0%   
Fx inflow Rs m058 0.0%   
Fx outflow Rs m02,350 0.0%   
Net fx Rs m0-2,293 -0.0%   
CASH FLOW
From Operations Rs m-16194 -171.3%  
From Investments Rs m-197-4 4,847.0%  
From Financial Activity Rs m295-112 -263.7%  
Net Cashflow Rs m-63-22 285.4%  

Share Holding

Indian Promoters % 72.9 49.0 148.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.9 3.2 274.1%  
FIIs % 8.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 27.2 51.1 53.2%  
Shareholders   251 6,984 3.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SOTAC PHARMACEUTICALS LTD. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SOTAC PHARMACEUTICALS LTD. vs SAMRAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SOTAC PHARMACEUTICALS LTD. vs SAMRAT PHARMA Share Price Performance

Period SOTAC PHARMACEUTICALS LTD. SAMRAT PHARMA S&P BSE HEALTHCARE
1-Day 0.00% -3.66% 0.11%
1-Month 0.38% -10.73% -3.22%
1-Year -7.60% 21.18% 42.65%
3-Year CAGR -0.77% 23.25% 19.86%
5-Year CAGR -0.46% 35.13% 25.90%

* Compound Annual Growth Rate

Here are more details on the SOTAC PHARMACEUTICALS LTD. share price and the SAMRAT PHARMA share price.

Moving on to shareholding structures...

The promoters of SOTAC PHARMACEUTICALS LTD. hold a 72.9% stake in the company. In case of SAMRAT PHARMA the stake stands at 49.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SOTAC PHARMACEUTICALS LTD. and the shareholding pattern of SAMRAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, SOTAC PHARMACEUTICALS LTD. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SAMRAT PHARMA paid Rs 1.0, and its dividend payout ratio stood at 14.3%.

You may visit here to review the dividend history of SOTAC PHARMACEUTICALS LTD., and the dividend history of SAMRAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.